Sanofi

Annual General Shareholders' Meeting of May 2, 2018

			Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY)
Annual General Shareholders' Meeting of May 2, 2018 Shareholders' approval of the financial statements for 2017 Dividend of €3.03 per share payable as of May 15, 2018 Board Composition: renewals and appointment   Paris (France) - May 2, 2018 - The Combined General Shareholders' Meeting of Sanofi was held today at the Palais des Congrès in Paris under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by its shareholders. The shareholders approved, among other resolutions, the individual Company and consolidated financial statements for the year 2017. At the General Meeting, shareholders decided the distribution of a cash dividend in the amount of € 3.03 per share with payment as of May 15, 2018. The General Meeting also renewed as Directors Olivier Brandicourt, Patrick Kron and Christian Mulliez and approved the appointment of Emmanuel Babeau as independent Director, for a term of four years, i.e., until the General Meeting called to approve the financial statements for the year 2021.  Following the General Meeting, the new Board of Directors is still comprised of 16 members, of whom six are women and two are Directors representing employees. A large majority of the Board's Directors is independent: Serge Weinberg*, Chairman of the Board of Directors Olivier Brandicourt, Chief Executive Officer Laurent Attal Emmanuel Babeau* Bernard Charlès* Claudie Haigneré* Patrick Kron* Fabienne Lecorvaisier* Melanie Lee* Suet-Fern Lee* Christian Mulliez Marion Palme** Carole Piwnica* Christian Senectaire** Diane Souza* Thomas Südhof*